APA (7th ed.) Citation

R, L., D, N., L, A., J, M., Y, F., & CU, C. (2023). Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM. Dove Medical Press.

Chicago Style (17th ed.) Citation

R, Litman, Naber D, Anta L, Martínez J, Filts Y, and Correll CU. Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM. Dove Medical Press, 2023.

MLA (9th ed.) Citation

R, Litman, et al. Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM. Dove Medical Press, 2023.